Navigation Links
Amylin Pharmaceuticals Reports 2008 Financial Results
Date:1/27/2009

The Company's results for the quarter ended December 31, 2008 include a charge of $54.9 million associated with the Company's restructuring. This charge consists primarily of one-time expenses related to facility leases, including impairments of related tenant improvements and employee termination benefits. Net loss excluding this charge was $49.1 million, or $0.36 per share. Non-GAAP operating loss, excluding non-cash items and the restructuring charge, was $20.2 million for the quarter ended December 31, 2008 compared to $47.0 million for the same period in 2007. Including the restructuring charge, GAAP net loss was $104.1 million, or $0.76 per share, for the quarter ended December 31, 2008, compared to $76.9 million, or $0.57 per share, for the same period in 2007.

Fourth quarter highlights

Highlights of Amylin's fourth quarter and recent activities include:

BYETTA

  • Communicated the addition of BYETTA to the American Diabetes Association's treatment guidelines for the medical management of type 2 diabetes.

Exenatide Once Weekly

  • Announced that the ongoing extension of the DURATION-1 study is appropriate to use as the basis for demonstrating comparability between intermediate-scale clinical trial material made in Alkermes' manufacturing facility, and commercial-scale drug product made at Amylin's manufacturing facility based on feedback from the U.S. Food and Drug Administration (FDA).
  • Reaffirmed plans for exenatide once weekly NDA submission to the FDA by the end of the first half of 2009.
  • Completed enrollment of DURATION-3, the third in a planned program of superiority clinical studies of exenatide once weekly, comparing exenatide once weekly to insulin glargine in patients using oral diabetes medications. Results from this study are expected in the t
    '/>"/>

SOURCE Amylin Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine news :

1. Amylin Pharmaceuticals to Webcast Year-End Results
2. Amylin Pharmaceuticals to Present at JPMorgan Healthcare Conference
3. Amylin, Lilly Update on FDA Review of BYETTA(R) (exenatide) Injection Monotherapy Submission
4. Amylin Pharmaceuticals to Present at Lazard Capital Markets Healthcare Conference
5. Lilly and Amylin Set Date and Time for Conference Call
6. Amylin Pharmaceuticals Diabetes Drug Byetta the Focus of California Lawsuit
7. Amylin Pharmaceuticals Reports First Quarter Financial Results
8. Amylin Pharmaceuticals Reports 2007 Financial Results
9. Xenome Enters Into Joint Research Collaboration to Discover Novel Peptide Therapeutics with Amylin Pharmaceuticals
10. Amylin Pharmaceuticals to Present at Research & Development Day
11. Amylin Pharmaceuticals to Webcast Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/30/2014)... Nutrition Leaders, a popular online retailer of sports ... is currently hosting a sweepstakes on its official Facebook ... to U.S. residents age 18 and over, and will ... winner will then be selected at random from all ... NutritionLeaders.com. , Nutrition Leaders’ managing director Kimba Vasquez views ...
(Date:10/30/2014)... Riverside, CA (PRWEB) October 30, 2014 ... these terms are synonymous with the craft of web ... and functional website. Yet a simpler solution to create ... , Thus, pictures, videos, contact information, customer reviews and ... website. , "It is the next evolution of ...
(Date:10/30/2014)... 2014 High efficacy and low ... the medical-grade skin care domain: Cosmederm, the specialty ... potent topical dermatological products, today announces the launch ... with patented COSMEDERM®-7 anti-irritant technology. , Formulated ... and 70%) and a low pH (pH 1.2 ...
(Date:10/30/2014)... Austin, TX (PRWEB) October 30, 2014 ... is gifting PreD Store shoppers with a ... taken before meals to reduce post-meal blood sugar spikes. ... overall health is an important part of a diabetes ... on orders will receive one complimentary tube of sugardown. ...
(Date:10/30/2014)... New Haven, CT (PRWEB) October 30, 2014 ... product categories are raising questions about the impact of ... as the marketing method most likely to influence a ... online research poll of 525 consumers conducted by radio ... in four product categories, isolating the results of respondents ...
Breaking Medicine News(10 mins):Health News:Nutrition Leaders Announces Gift Card Sweepstakes 2Health News:Facebook Websites In Thirty-Seconds 2Health News:Cosmederm Redefines Peel Science Standard with Launch of Refinity® Skin Health System 2Health News:Cosmederm Redefines Peel Science Standard with Launch of Refinity® Skin Health System 3Health News:Cosmederm Redefines Peel Science Standard with Launch of Refinity® Skin Health System 4Health News:PreDiabetes Treatment Company Offers PreD Store Shoppers Supplements to Support Healthy Blood Sugar 2Health News:CRN Research On Radio Messaging Effectiveness Now Available In Four Specific Product Categories 2Health News:CRN Research On Radio Messaging Effectiveness Now Available In Four Specific Product Categories 3
... TERRACE, Ill., Dec. 15 Dental Network of America,Inc. (DNoA), ... national,dental network -- the DNoA Preferred Network -- now totaling ... This significant network growth places DNoA as the ... States, per NetMinder data as of,September 2008, powered by The ...
... Dec. 15 issue of the Journal of Clinical Sleep ... start times, teens increased their average nightly hours of sleep ... were involved in fewer auto accidents. , When school ... nine) to 30 minutes (grade 12) more self-reported nightly sleep. ...
... fly,s immune system can tell time, researchers at the ... hard it punches back against infections depends on whether ... have implications for human health, too. , Working with ... and with syringes small enough to inject measured amounts ...
... event to Improve Your Sales Process in a Way Your Customers Will ... introducing the book will be held on Dec 18, 2008 at 3:00 ... ... everywhere are struggling to find ways of generating more revenue with fewer ...
... benign breast disease (BBD) known as atypical hyperplasia substantially ... even if there is no history of breast cancer ... The investigators, who presented their findings at the Cancer ... San Antonio Breast Cancer Symposium, say the women they ...
... MyPyramid for Preschoolers, helps parents expand little ones, diet ... News) -- A new federal government food pyramid for ... especially as youngsters are introduced to new kinds of ... interactive Web site (MyPyramid.gov) offers individualized nutrition guidance to ...
Cached Medicine News:Health News:Dental Network of America Becomes Largest National Dental Network in the U.S. 2Health News:Later school start times may improve sleep in adolescents and decrease risk of auto accidents 2Health News:Snoring or soaring? Strength of fruit-fly immune system varies 2Health News:Snoring or soaring? Strength of fruit-fly immune system varies 3Health News:New Guidebook Published for Improving B2B Sales Results in 90 Days or Less Through Kaizen Events 2Health News:New Guidebook Published for Improving B2B Sales Results in 90 Days or Less Through Kaizen Events 3Health News:Breast cancer risk varies in young women with benign breast disease, Mayo Clinic researchers say 2Health News:Breast cancer risk varies in young women with benign breast disease, Mayo Clinic researchers say 3Health News:New Food Pyramid Is Aimed at Kids 2
(Date:10/30/2014)... , Oct. 30, 2014  TWi Pharmaceuticals, Inc. ... the United States Food and Drug Administration (FDA) on ... Tablets USP, 23 mg, the generic equivalent to Eisai ... Alzheimer,s disease patients. TWi Pharmaceuticals is preparing ... fully owned subsidiary, TWi Pharmaceuticals USA ...
(Date:10/30/2014)... YORK , Oct. 29, 2014 ... the basis of test type, technology, product, and ... register the highest growth rate in the newborn ... This high growth is attributed to various nations ... is a fundamental instrument used for expanded newborn ...
(Date:10/30/2014)... , Oct. 29, 2014   ViaDerma, ... devoted to bringing new products to market, is ... ViaDerma has developed an innovative, patent-pending dual ... mass transfer of pharmaceutical active ingredients to penetrate ... immediate localized therapy. The transdermal delivery method also ...
Breaking Medicine Technology:NewBorn Screening Market by Test Type, Technology (Tandem Mass Spectrometry, Immunoassay, Enzyme Assay, Electrophoresis, Pulse Oximeter), Instrument, Accessories, Reagent & Assay Kit - Global Forecast to 2019 2NewBorn Screening Market by Test Type, Technology (Tandem Mass Spectrometry, Immunoassay, Enzyme Assay, Electrophoresis, Pulse Oximeter), Instrument, Accessories, Reagent & Assay Kit - Global Forecast to 2019 3ViaDerma, Inc. Announces Plans to Pursue Out-Licensing Partnerships in 2015 2ViaDerma, Inc. Announces Plans to Pursue Out-Licensing Partnerships in 2015 3
... Labs, Inc. (OTC,Bulletin Board: GOVX), an Atlanta- based ... entered into a $10 million common,stock purchase agreement ... investor., The Company may sell up to ... from time to time over a 25-month period ...
... Arbios Systems, Inc.,(OTC Bulletin Board: ABOS) announced today ... Food and Drug Administration ("FDA") of an,Investigational Device ... SEPET(TM), Arbios, extracorporeal (outside the body) liver assist,device ... from,chronic liver disease., "We are pleased to ...
Cached Medicine Technology:GeoVax Secures $10 Million Financing Commitment 2GeoVax Secures $10 Million Financing Commitment 3Arbios Receives Approval From the FDA to Initiate Pivotal Trial for SEPET(TM) Liver Assist Device 2Arbios Receives Approval From the FDA to Initiate Pivotal Trial for SEPET(TM) Liver Assist Device 3Arbios Receives Approval From the FDA to Initiate Pivotal Trial for SEPET(TM) Liver Assist Device 4Arbios Receives Approval From the FDA to Initiate Pivotal Trial for SEPET(TM) Liver Assist Device 5
... objective has a higher numerical aperture and ... helps eliminate surface,reflections and provides an image ... objective for fluorescence, brightfield and DIC observation ... collar that allows it to be used ...
The KL 2500 LCD is Schott's most powerful cold light source which makes it ideal for special applications. A 250W halogen reflector lamp provides more than twice as much light as the KL 1500 LCD....
... superb field flatness, high UV transmission ... extra long working distances, these objectives ... with inverted microscopes. Because of their ... ELWD DM,objectives can be used universally ...
... CKX microscopes utilize the infinity-corrected ... and operability in cell checking. ... inverted microscope suited to routine ... fields--from tissue culture and embryology ...
Medicine Products: